Cargando…
SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients
INTRODUCTION: Fibrodysplasia ossificans progressiva (FOP) is characterized by progressive heterotopic ossification triggered by various conditions, such as trauma, infection, including COVID-19 infection, and vaccination. Although SARS-CoV-2 vaccinations prevent poor outcomes in the general populati...
Autores principales: | Smetanova, Jitka, Milota, Tomas, Rataj, Michal, Hurnakova, Jana, Zelena, Hana, Horvath, Rudolf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682080/ https://www.ncbi.nlm.nih.gov/pubmed/36439163 http://dx.doi.org/10.3389/fimmu.2022.1017232 |
Ejemplares similares
-
Immunogenicity and safety of the booster BNT162b2 vaccine in patients with axial spondyloarthritis treated with biological disease-modifying drugs
por: Smetanova, Jitka, et al.
Publicado: (2022) -
Fibrodysplasia ossificans progressiva
por: Smit, Chané, et al.
Publicado: (2023) -
Recent Topics in Fibrodysplasia Ossificans Progressiva
por: Katagiri, Takenobu, et al.
Publicado: (2018) -
The Diversity of the Clinical Phenotypes in Patients With Fibrodysplasia Ossificans Progressiva
por: Al Kaissi, Ali, et al.
Publicado: (2016) -
Fibrodysplasia Ossificans Progressiva: Clinical and Genetic Aspects
por: Pignolo, Robert J, et al.
Publicado: (2011)